Anthony Aho, CEO & Co-Founder of PB&B Ltd. (www.pbbtech.com): Facial & Body Remodeling Medical Technology.

• PB&B’s novel injectable technology allows plastic surgeons and dermatologists to enhance fat tissue volume with lipids to naturally remodel facial and body areas.
• Patent granted to date in 9 countries (USA, Japan, Korea,…) with all claims and applications. Full FTO (Freedom-to-Operate).
• Developed by an international team of plastic surgeons and bioengineers, clinical testing will begin in Q4-2020 towards an FDA approval + CE mark expected by the end of 2022-23.
• PB&B has won numerous innovation and startup awards, including the IMCAS Innovation of the Year award 2018 (largest global medical aesthetics congress – Paris, France).
• 3 Innovation government grants approved based on innovation & market potential.
• PB&B is raising a $5 MM Series B1 (30% already funded) and $18M in total Series B funding for FDA approval. Funding to date: $5.4 million.